Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Discover the full record of transactions filed by Alessandro RIVA, Chairman of the Board. Officer active across 1 company, notably Transgene S.A.. Cumulatively, 1 disclosures have been published. Split: 1 buy · 0 sell. History available since 26 May 2023. The latest transaction was disclosed on 26 May 2023 (Acquisition). Regulator: AMF. The full history is openly available.
1 of 1 declaration
Alessandro RIVA is the Chairman of the Board of TRANSGENE S.A. As chairman, he plays a key role in the governance of the company, leading board meetings and ensuring that strategic decisions align with the company's objectives. His experience in the biopharmaceutical sector is an asset for the company.